Compare · CHE vs PIII
CHE vs PIII
Side-by-side comparison of Chemed Corp (CHE) and P3 Health Partners Inc. (PIII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and PIII operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $7.14B, about 36.5x PIII ($195.4M).
- Over the past year, CHE is down 25.4% and PIII is down 70.1% - CHE leads by 44.7 points.
- CHE has been more active in the news (6 items in the past 4 weeks vs 2 for PIII).
- CHE has more recent analyst coverage (6 ratings vs 5 for PIII).
- Company
- Chemed Corp
- P3 Health Partners Inc.
- Price
- $421.57+9.84%
- $2.71-4.24%
- Market cap
- $7.14B
- $195.4M
- 1M return
- +12.75%
- -10.26%
- 1Y return
- -25.40%
- -70.09%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 6
- 2
- Recent ratings
- 6
- 5
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
P3 Health Partners Inc.
P3 Health Partners Inc. provides primary health care services. The company offers clinical operations and population health management services, as well as provides senior wellness centers. The company is based in Henderson, Nevada.
Latest CHE
- Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chemed Reports First-Quarter 2026 Results
- Chemed Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement
- SEC Form DEFR14A filed by Chemed Corp
- SEC Form DEF 14A filed by Chemed Corp
- Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24
- Roto-Rooter Completes Acquisitions for Two Significant Territories
- SEC Form 4 filed by Mcnamara Kevin J
- Now Open: VITAS® Healthcare Inpatient Hospice Care at Oak Manor
Latest PIII
- SEC Form PRE 14A filed by P3 Health Partners Inc.
- P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call
- SEC Form S-8 filed by P3 Health Partners Inc.
- SEC Form 10-K filed by P3 Health Partners Inc.
- P3 Health Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
- P3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
- P3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Amendment: Director Wasson Gregory D was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)